Skip to main content

Table 4 Comparison of HR-HPV prevalence and genotypic distribution in screening settings in various countries

From: Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs

Study/year

Site/N

HPV Test

HR-HPV*

16

18

31

33

35

39

45

51

52

56

58

59

N (%)

Ralston Howe E (15)

USA

PCR

13444

4507

881

1757

524

479

306

734

26

2009

437

865

919

2009

73371

 

(18.3)

(33.5)

(6.6)

(13.1)

(3.9)

(3.6)

(2.3)

(5.5)

(0.2)

(14.9)

(3.3)

(6.4)

(6.8)

Dickson EL (16) **

USA

PCR

11.9%

4.1%

0.7%

1.9%

0.4%

0.3%

 

0.5%

-

2.1%

-

1.1%

0.8%

2013

309471

 

(100)

(34.5)

(5.9)

(16.0)

(3.4)

(2.5)

-

(4.2)

 

(17.6)

 

(9.2)

(6.7)

Agarossi A (17)

Italy

HC2 followed by PCR

1403

415

150

211

61

67

111

68

132

67

142

120

45

2009

9946

(14.1)

(29.6)

(10.7)

(15.0)

(4.3)

(4.8)

(7.9)

(4.8)

(9.4)

(4.8)

(10.1)

(8.6)

(3.2)

Anderson L (18) **

Ireland

Cobas4800 test followed by Linear array

16.6%

3.2%

1.2%

1.8%

1.2%

0.5%

1.2%

1.0%

1.6%

1.5%

1.0%

0.8%

1.6%

2012

5712

(100)

(19.3)

(7.2)

(10.8)

(7.2)

(3.0)

(7.2)

(6.0)

(9.6)

(9.0)

(6.0)

(4.8)

(9.6)

Ucakar V (19)

Slovenia

HC2/Real Time PCR followed by Linear array

502

155

46

114

32

9

50

42

81

78

31

29

29

2012

4431

(11.3)

(30.9)

(9.2)

(22.7)

(6.4)

(1.8)

(10.0)

(8.4)

(16.1)

(15.5)

(6.2)

(5.8)

(5.8)

INOUE M (23)

Japan

HC2 followed by HPVDNAChip (Biomedlab Co., South Korea)

632

167

73

50

17

7

43

20

98

189

100

131

39

2006

8156

(7.7)

(22.7)

(9.9)

(6.8)

(2.3)

(1.0)

(5.9)

(2.7)

(13.3)

(25.7)

(13.6)

(17.8)

(5.3)

Li H (24)

China

HPV GenoArray (Hybribio, Hong Kong)

755

233

64

26

30

3

44

9

20

163

27

119

17

2013

3640

(20.7)

(30.9)

(8.5)

(3.4)

(4.0)

(0.4)

(5.8)

(1.2)

(2.6)

(21.5)

(3.6)

(15.8)

(2.3)

Zhoa FH (31)

China

SPF PCR-DEIA-LiPA (LaboBiomedial Product, Rijswijk, the Netherlands)

924

222

74

59

65

31

81

33

102

243

69

90

22

2014

6035

(15.3)

(3.7)

(1.2)

(1.0)

(1.1)

(0.5)

(1.3)

(0.5)

(1.7)

(4.0)

(1.1)

(1.5)

(0.4)

This study

Thailand

Linear array (Roche, USA)

376

80

35

18

13

7

33

11

55

94

19

47

18

2015

5906

(6.4)

(21.2)

(9.3)

(4.8)

(3.5)

(1.9)

(8.8)

(2.9)

(14.6)

(25.0)

(5.1)

(12.5)

(4.8)

  1. *HR-HPV included 12 HPV types as 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59.
  2. **Reported as percentage in total population.
  3. HC2: Hybrid Capture 2 (Qiagen, Hilden, Germany), PCR: polymerase chain reaction.